• Veru Announces New England Journal of Medicine Evidence Publication of Phase 3 Clinical Trial Results Demonstrating that Sabizabulin Treatment Significantly Reduced Deaths in High-Risk Hospitalized COVID-19 Patients

    Source: Nasdaq GlobeNewswire / 06 Jul 2022 07:30:45   America/New_York

    N/A
Share on,